Method of Selecting Cancer Patients For Anti-Angiogenesis Therapy Read more about Method of Selecting Cancer Patients For Anti-Angiogenesis Therapy US Application 61/448,092Filed on 2011-03-01
Tropolone Compounds For Treating Or Preventing Retroviral Infection Read more about Tropolone Compounds For Treating Or Preventing Retroviral Infection US Application 61/484,779Filed on 2011-05-11
Human Monoclonal Antibodies That Bind Insulin-like Growth Factor (IGF) I And II Read more about Human Monoclonal Antibodies That Bind Insulin-like Growth Factor (IGF) I And II US Application 61/474,664Filed on 2011-04-12
High-affinity Fully Functional Soluble Single-domain Human CD4 Read more about High-affinity Fully Functional Soluble Single-domain Human CD4 US Application 61/467,570Filed on 2011-03-25
Combination Chemotherapy For The Treating Cancer Read more about Combination Chemotherapy For The Treating Cancer US Application 61/451,925Filed on 2011-03-11
METHODS OF TREATING PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH AN ANTI-CD22 IMMUNOTOXIN Read more about METHODS OF TREATING PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH AN ANTI-CD22 IMMUNOTOXIN US Application 61/372,813Filed on 2010-08-11
A New Chemical Class Of Antiandrogen For The Treatment Of Castrate-resistant Prostate Cancer Read more about A New Chemical Class Of Antiandrogen For The Treatment Of Castrate-resistant Prostate Cancer US Application 61/497,129Filed on 2011-06-15
Layered Electrophoretic Transfer Read more about Layered Electrophoretic Transfer US Application 61/420,258Filed on 2010-12-06
Synthetic Peptide Inhibitors Of Wnt Pathway Read more about Synthetic Peptide Inhibitors Of Wnt Pathway US Application 61/422,857Filed on 2010-12-14
Allele Specific ShRNAs For Nanog, Pharmaceutical Composition Comprising The SHRNA, And Its Method of Use to Treat Cancer Read more about Allele Specific ShRNAs For Nanog, Pharmaceutical Composition Comprising The SHRNA, And Its Method of Use to Treat Cancer US Application 61/420,214Filed on 2010-12-06